Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review

被引:5
作者
Guo, Ge [1 ]
Zhou, Juhua [1 ]
Yang, Xiaogaung [2 ]
Feng, Jiang [2 ]
Shao, Yanxia [1 ]
Jia, Tingting [1 ]
Huang, Qingrong [1 ]
Li, Yanmin [1 ]
Zhong, Yin [3 ]
Nagarkatti, Prakash S. [3 ]
Nagarkatti, Mitzi [3 ]
机构
[1] Ludong Univ, Yantai, Shandong, Peoples R China
[2] Hangzhou Hesti Biotechnol Co Ltd, Hangzhou, Zhejiang, Peoples R China
[3] Univ South Carolina, Columbia, SC USA
关键词
miRNAs; Chinese herbal medicines; hepatocellular carcinoma; EPITHELIAL-MESENCHYMAL TRANSITION; RENAL-CELL CARCINOMA; LIVER-CANCER; IN-VITRO; SIGNALING PATHWAY; MORTALITY-RATES; DOWN-REGULATION; TUMOR-GROWTH; MIGRATION; PROLIFERATION;
D O I
10.1177/1534735418805564
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are highly conserved, noncoding small RNAs that regulate gene expression, and consequently several important functions including early embryo development, cell cycle, programmed cell death, cell differentiation, and metabolism. While there are no effective treatments available against hepatocellular carcinoma (HCC), some Chinese herbal medicines have been shown to regulate growth, differentiation, invasion, and metastasis of HCC. Many studies have shown that Chinese herbal medicines regulate the expression of miRNAs and this may be associated with their ability to control the development of HCC. In this article, the effects of Chinese herbal medicines on the expression of miRNAs and their functions in the regulation of HCC have been reviewed and discussed. miRNAs such as miRNA-221 and miRNA-222 mediated by Chinese herbal medicines may be good biomarkers and therapeutic targets for HCC.
引用
收藏
页码:1059 / 1067
页数:9
相关论文
共 76 条
[1]   Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States [J].
Altekruse, Sean F. ;
Henley, S. Jane ;
Cucinelli, James E. ;
McGlynn, Katherine A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (04) :542-553
[2]   MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways [J].
Bao, Longlong ;
Yan, Yan ;
Xu, Can ;
Ji, Weidan ;
Shen, Shuwen ;
Xu, Gaoya ;
Zeng, Yong ;
Sun, Bin ;
Qian, Haihua ;
Chen, Lei ;
Wu, Mengchao ;
Su, Changqing ;
Chen, Jie .
CANCER LETTERS, 2013, 337 (02) :226-236
[3]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[4]   MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches [J].
Callegari, E. ;
Gramantieri, L. ;
Domenicali, M. ;
D'Abundo, L. ;
Sabbioni, S. ;
Negrini, M. .
CELL DEATH AND DIFFERENTIATION, 2015, 22 (01) :46-57
[5]   MicroRNA function in Drosophila melanogaster [J].
Carthew, Richard W. ;
Agbu, Pamela ;
Giri, Ritika .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2017, 65 :29-37
[6]   EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis [J].
Chen, Shaofei ;
Pu, Jiarui ;
Bai, Jie ;
Yin, Yuping ;
Wu, Ke ;
Wang, Jiliang ;
Shuai, Xiaoming ;
Gao, Jinbo ;
Tao, Kaixiong ;
Wang, Guobin ;
Li, Hang .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
[7]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[8]   Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice [J].
Chou, Shun-Ting ;
Hsiang, Chien-Yun ;
Lo, Hsin-Yi ;
Huang, Hui-Fen ;
Lai, Ming-Tsung ;
Hsieh, Ching-Liang ;
Chiang, Su-Yin ;
Ho, Tin-Yun .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 17
[9]  
Deng Hui, 2017, Zhongguo Zhong Yao Za Zhi, V42, P130, DOI 10.19540/j.cnki.cjcmm.20161222.007
[10]   Holotransferrin Enhances Selective Anticancer Activity of Artemisinin against Human Hepatocellular Carcinoma Cells [J].
Deng, Xiao-rong ;
Liu, Zhao-xia ;
Liu, Feng ;
Pan, Lei ;
Yu, He-ping ;
Jiang, Jin-ping ;
Zhang, Jian-jun ;
Liu, Li ;
Yu, Jun .
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (06) :862-865